Mineral Resources reports a robust earnings update with significant revenue growth, strategic leadership changes, and a shareholder-friendly interim dividend, reflecting strong operational performance and future optimism.
Pilbara Minerals faces a challenging half-year with a sharp revenue drop, countered by strategic expansions and efficiencies aimed at leveraging future lithium market recoveries.
The company made significant investments for growth, including increasing its shareholding in Transmedic and acquiring Superior Pet Food Co. Ebos’s strategy includes further expansion in Southeast Asia and enhancing its product portfolio through acquisitions and new product development.
A softer than expected 1H revenue and EBITDA result was observed due to two main factors: negative travel sentiment from the conflict in the Middle East and corporate customer budgets being fully utilized by September 2023 due to high ticket prices, particularly in the northern hemisphere. However, an encouraging rebound in January activity implies these issues have dissipated.
We have seen Mineral Resources share price drop over the past month due to decreasing Spodumene Concentrate prices in China. Despite this drop we believe at current prices, this presents a good opportunity.
We have seen Mineral Resources share price drop over the past month due to decreasing Spodumene Concentrate prices in China. Despite this drop we believe at current prices, this presents a good opportunity.
Value switch in the agricultural sector
ETPMAG is backed by physical silver. Each physical bar is segregated, individually identified and allocated.
Switching from Neuren Pharma (NEU) to Telix Pharma (TLX) in our balanced portfolio, capitalizing on Telix’s innovative cancer treatment advancements and market potential.
The final leg of our agricultural earnings season strategy, we are recommending a switching the 2% allocation in Nufarm to GrainCorp
This website provides general advice that does not take into account your individual objectives, financial situation, or needs. Past performance does not guarantee future results. The trade recommendations in our Pilot Portfolios are hypothetical, may exclude certain fees, and are not a basis for future investment decisions. Please do not rely solely on this information. We recommend seeking appropriate financial, taxation, and legal advice before making any investment decisions. Please refer to our Financial Services Guide for more information about our services.